Single group multisite safety trial of sibling cord blood cell infusion to children with cerebral palsy: study protocol and rationale

BMJ Open
Kylie E CromptonDinah Reddihough

Abstract

Cerebral palsy (CP) is the most common physical disability of childhood but has no cure. Stem cells have the potential to improve brain injury and are proposed as a therapy for CP. However, many questions remain unanswered about the most appropriate cell type, timing of infusions, dose required and associated risks. Therefore, human safety and efficacy trials are necessary to progress knowledge in the field. This is a single group study with sample size n=12 to investigate safety of single-dose intravenous 12/12 human leucocyte antigen-matched sibling cord blood cell infusion to children with CP aged 1-16 years without immune suppression. The study is similar to a 3+3 design, where the first two groups of participants have severe CP, and the final six participants include children with all motor severities. Children will be monitored for adverse events and the duration that donor cells are detected. Assessments at baseline, 3 and 12 months will investigate safety and preliminary evidence of change in gross motor, fine motor, cognitive and quality of life outcomes. Full approval was obtained from The Royal Children's Hospital Human Research Ethics Committee, and a clinical trial notification was accepted by Australia's Therapeut...Continue Reading

Associated Clinical Trials

References

Apr 1, 1997·Developmental Medicine and Child Neurology·R PalisanoB Galuppi
Sep 24, 1998·Developmental Medicine and Child Neurology·N BadawiF Stanley
Jul 15, 2003·Journal of Hematotherapy & Stem Cell Research·Samuel SaportaPaul R Sanberg
Jul 18, 2003·Journal of Neuroscience Research·A E WillingP R Sanberg
Sep 4, 2004·Stroke; a Journal of Cerebral Circulation·Cesar V BorlonganPaul R Sanberg
Mar 21, 2007·Developmental Medicine and Child Neurology. Supplement·Peter RosenbaumBo Jacobsson
Mar 23, 2007·Journal of Neurotrauma·Venkata Ramesh DasariDzung H Dinh
Jul 11, 2009·Acta Haematologica·Guillermo J Ruiz-DelgadoGuillermo J Ruiz-Argüelles
Aug 22, 2009·Developmental Medicine and Child Neurology·Sarah McIntyreAnne Cusick
Oct 6, 2009·Bone Marrow Transplantation·E Gluckman
Jun 10, 2010·Stem Cell Reviews and Reports·Dong-Hyuk ParkTai-Hyoung Cho
May 28, 2011·Brain : a Journal of Neurology·Robert H AndresGary K Steinberg
Aug 16, 2011·Physical & Occupational Therapy in Pediatrics·Megan ThorleyRoslyn Boyd
Jan 26, 2013·Developmental Medicine and Child Neurology·Maryam OskouiTamara Pringsheim
Nov 26, 2013·Sociology of Health & Illness·Alan PetersenMegan Munsie
Jun 6, 2014·Clinical Chemistry·Damien L BrunoHoward R Slater
Oct 3, 2017·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Ryu YanagisawaTomohiko Nakamura

❮ Previous
Next ❯

Citations

Aug 12, 2021·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Madison Claire Badawy PatonIona Novak

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

REDCap
QUEST
Research Electronic Data Capture ( REDCap )

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.